The use of the levonorgestrel-releasing intrauterine system in the management of menorrhagia in women with hemostatic disorders.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 16202726.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The study was undertaken to evaluate the levonorgestrel-releasing intrauterine system (LNG-IUS) in managing menorrhagia associated with hemostatic disorders. Retrospective notes review. Nineteen of 28 (68%) patients experienced improvement with the LNG-IUS. There was nonacceptance by 9 of 28 (32%) who refused the LNG-IUS or had it definitively removed. The LNG-IUS should be considered when managing menorrhagia because surgery carries additional risks in this subset of patients.
Medical subject headings
- Hemostatic Disorders
- Levonorgestrel
- Menorrhagia